Search

Your search keyword '"Joensuu H"' showing total 1,371 results

Search Constraints

Start Over You searched for: Author "Joensuu H" Remove constraint Author: "Joensuu H"
1,371 results on '"Joensuu H"'

Search Results

1. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

3. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

5. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

6. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

7. Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels

8. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

9. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

10. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

12. Effizienz und Sicherheit von Darolutamid (DARO) in Kombination mit Androgendeprivationstherapie (ADT) und Docetaxel (DOC) nach Krankheitsvolumen und -risiko in der Phase 3 ARASENS Studie

13. Lebensqualität und Patienten-relevante Endpunkte unter Darolutamid-Therapie in der Phase-3-Studie ARASENS

16. New insights into the genetic etiology of Alzheimer's disease and related dementias

17. 173P Clinical outcomes in stratification subgroups in the ARASENS study in metastatic hormone-sensitive prostate cancer (mHSPC)

18. Pancreatic cancer risk after treatment of Hodgkin lymphoma

21. 1360MO Quality of life and patient-relevant endpoints with darolutamide in the phase III ARASENS study

25. Large Animal Model for Healthy Tissue Tolerance Study in BNCT

27. Risk of treatment-related esophageal cancer among breast cancer survivors

32. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

33. Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

34. Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study

35. Outcome and biomarker supervised deep learning for survival prediction in two multicenter breast cancer series

36. Does Soluble CD44 Reflect the Clinical Behavior of Human Cancer?

38. Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

39. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

44. LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer

45. Adjuvant imatinib for GIST : duration likely matters

46. Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy

Catalog

Books, media, physical & digital resources